Literature DB >> 10996126

Schistosoma mansoni: assessment of morbidity before and after control.

J R Lambertucci1, J C Serufo, R Gerspacher-Lara, A A Rayes, R Teixeira, V Nobre, C M Antunes.   

Abstract

The literature on the assessment of morbidity due to Schistosoma mansoni infection is updated. Imaging techniques such as ultrasonography, echodoppler cardiography, computerized tomography (CT scan) and magnetic resonance imaging (MRI) introduced a new perspective, and expanded our knowledge on morbidity. Three well-defined syndromes caused by schistosomiasis mansoni have been described: the stage of invasion, acute schistosomiasis (Katayama fever), and chronic schistosomiasis. Complications of the acute and chronic syndromes have also been reported: pulmonary hypertension, neuroschistosomiasis, association with Salmonella, association with Staphylococci, viral hepatitis B, glomerulonephritis. In most individuals with hepatosplenic schistosomiasis the spleen is increased in size. Hepatosplenic schistosomiasis can, however, occur without splenomegaly. The definition of hepatosplenic schistosomiasis in endemic areas as the finding of S. mansoni eggs in the stools in an individual with hepatosplenomegaly is not satisfactory anymore. Many aspects of morbidity are expected to change after schistosomiasis control. Some are expected to change quickly (worm burden, Salmonella bacteremia, hepatosplenic schistosomiasis in children) whereas others shall remain for years (pulmonary hypertension, glomerulonephritis, neuroschistosomiasis). Intestinal schistosomiasis in individuals with low worm burdens is very difficult to diagnose and therefore laborious to control.

Entities:  

Mesh:

Year:  2000        PMID: 10996126     DOI: 10.1016/s0001-706x(00)00124-8

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  24 in total

1.  A case of bowel schistosomiasis not adhering to endoscopic findings.

Authors:  Manfredi Rizzo; Pasquale Mansueto; Daniela Cabibi; Elisabetta Barresi; Kaspar Berneis; Mario Affronti; Gabriele Di Lorenzo; Sergio Vigneri; Giovam Battista Rini
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  The genomic proliferation of transposable elements in colonizing populations: Schistosoma mansoni in the new world.

Authors:  Bhagya K Wijayawardena; J Andrew DeWoody; Dennis J Minchella
Journal:  Genetica       Date:  2015-02-14       Impact factor: 1.082

3.  Schistosomiasis--An unusual cause of abdominal pseudotumor.

Authors:  Akintayo Oguntona Segun; Christopher Olutayo Alebiosu; A O J Agboola; A A F Banjo
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

4.  Diagnostic and prognostic value of cell free circulating Schistosoma mansoni DNA: an experimental study.

Authors:  Maysa Ahmad Eraky; Nagwa Shaban Mohamed Aly
Journal:  J Parasit Dis       Date:  2014-12-20

5.  Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification.

Authors:  Yulan Wang; Elaine Holmes; Jeremy K Nicholson; Olivier Cloarec; Jacques Chollet; Marcel Tanner; Burton H Singer; Jürg Utzinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

6.  Selectins and platelet-derived growth factor (PDGF) in schistosomiasis-associated pulmonary hypertension.

Authors:  Monica Lapa; Milena M P Acencio; Alberto Q Farias; Lisete R Teixeira; Caio J C Fernandes; Carlos P Jardim; Mario Terra-Filho
Journal:  Lung       Date:  2014-09-14       Impact factor: 2.584

7.  Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni.

Authors:  Thiago A Pereira; Guanhua Xie; Steve S Choi; Wing-Kin Syn; Izabela Voieta; Jiuyi Lu; Isaac S Chan; Marzena Swiderska; Kirsten B Amaral; Carlos M Antunes; William E Secor; Rafal P Witek; José R Lambertucci; Fausto L Pereira; Anna Mae Diehl
Journal:  Liver Int       Date:  2012-11-01       Impact factor: 5.828

8.  Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.

Authors:  P Martins-Leite; G Gazzinelli; L F Alves-Oliveira; A Gazzinelli; L C C Malaquias; R Correa-Oliveira; A Teixeira-Carvalho; A M S Silveira
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

9.  Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores.

Authors:  Florent Martin; Marie-France Penet; Fabrice Malergue; Hubert Lepidi; Alain Dessein; Franck Galland; Max de Reggi; Philippe Naquet; Bouchra Gharib
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 10.  Human schistosomiasis.

Authors:  Daniel G Colley; Amaya L Bustinduy; W Evan Secor; Charles H King
Journal:  Lancet       Date:  2014-04-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.